Marc-Andre D'Aoust

USPTO Granted Patents = 34 (Patent Applications = 15)

CIPO Patents = 17 (Patent Applications = 11)

EPO Patents = 21 (Patent Applications = 32)

Average Co-Inventor Count = 3.6

ph-index = 3

Forward Citations = 22(Granted Patents)

Location History:

Quebec, CA (2013 - 2024)
Québec, CA (2016 - 2024)

Company Filing History:

Aramis Biotechnologies Inc.

Plant Bioscience Limited

patents

6. 1 out of 257

Mitsubishi Tanabe Pharma Corporation

patents

7. 1 out of 1

Medicago Inc. of Quebec, Canada

patent

where one patent can have more than one assignee

Years Active: 2013-2025

Loading Chart...

34 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12428661 - Influenza virus hemagglutinin mutants (2025-09-30),

2. 12180491 - Plant expression enhancer (2024-12-31),

3. 12146145 - Endogenous plant expression enhancer (2024-11-19),

4. 12139511 - Influenza virus hemagglutinin mutants (2024-11-12),

5. 12104196 - Influenza virus hemagglutinin mutants (2024-10-01),

6. 12076388 - Modified norovirus VP1 proteins and VLPS comprising modified norovirus VP1 proteins (2024-09-03),

7. 11987601 - Norovirus fusion proteins and VLPs comprising norovirus fusion proteins (2024-05-21),

8. 11959088 - Modifying protein production in plants (2024-04-16),

9. 11884929 - CPMV enhancer elements (2024-01-30),

10. 11833200 - Method of preparing plant-derived proteins (2023-12-05),

11. 11826419 - Method of preparing plant-derived VLPs (2023-11-28),

12. 11759512 - Modified norovirus VP1 proteins and VLPs comprising modified norovirus VP1 proteins (2023-09-19),

13. 11608361 - Norovirus fusion proteins and VLPS comprising norovirus fusion proteins (2023-03-21),

14. 11602558 - Modified norovirus VP1 proteins and VLPS comprising modified norovirus VP1 proteins (2023-03-14),

15. 11576317 - Mutantplant or cell with reduced XylT and FucT (2023-02-14),

Title: Innovations and Contributions of Marc-Andre D'Aoust

Introduction

Marc-Andre D'Aoust is a prolific inventor based in Quebec, Canada, with an impressive portfolio of 33 patents. His research predominantly focuses on enhancing plant expression, showcasing his significant contributions to agricultural biotechnology. D'Aoust's work has paved the way for innovative solutions that aim to improve plant growth and resilience.

Latest Patents

Among his latest patents, Marc-Andre D'Aoust has developed various isolated expression enhancers that play a crucial role in plant biology. These enhancers include specific sequences such as nbMT78, nbATL75, and nbH2A86, among others. His patents detail methods for utilizing these enhancers to boost the expression of desired traits in plants. The isolated expression enhancers he has identified are essential for boosting endogenous expressions, enhancing both plant health and productivity.

Career Highlights

Throughout his career, Marc-Andre D'Aoust has worked with leading companies in the biotech field, notably Medicago Inc. and Aramis Biotechnologies Inc. His innovative work in these organizations has contributed to breakthroughs in plant-based technologies, reflecting his commitment to advancing agricultural sciences.

Collaborations

D'Aoust has collaborated with various professionals in the field, including notable coworkers Pierre-Olivier Lavoie and Louis-Philippe Vezina. These collaborations have further enriched his research endeavors and expanded the impact of his innovations in plant biotechnology.

Conclusion

Marc-Andre D'Aoust's extensive work and numerous patents highlight his dedication to enhancing agricultural practices through innovative biotechnology. His findings continue to influence the way we understand and improve plant expression, signifying his important role in the future of agricultural innovations.

This text is generated by artificial intelligence and may not be accurate.